Bandingkan Harga & Kinerja Mulia Industrindo Tbk (MLIA) vs Brigit Biofarmaka Teknologi Tbk. (OBAT)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Mulia Industrindo Tbk dan Brigit Biofarmaka Teknologi Tbk.: Mulia Industrindo Tbk diperdagangkan di Rp230 (kapitalisasi pasar 1,52 T, volume 24 jam 35 rb), sedangkan Brigit Biofarmaka Teknologi Tbk. diperdagangkan di Rp242 (kapitalisasi pasar 164,65 M, volume 24 jam 187,4 rb). Perbedaan utamanya: Mulia Industrindo Tbk jauh lebih besar — sekitar 9,2× kapitalisasi pasar Brigit Biofarmaka Teknologi Tbk., dan Brigit Biofarmaka Teknologi Tbk. lebih aktif diperdagangkan (187,4 rb vs 35 rb). Mana yang lebih baik tergantung tujuan investasimu.
| MLIA | OBAT | |
|---|---|---|
Kapitalisasi Pasar | 1,52 T | 164,65 M |
Volume | 35 rb | 187,4 rb |
Lot | 350 | 1,87 rb |
Perputaran | 8,05 jt | 44,35 jt |
Harga Rata-rata | 230 | 236,67 |
Nilai Transaksi | 8,05 jt | 44,35 jt |
Harga Ekuilibrium Indikatif | 230 | 242 |
Volume Ekuilibrium Indikatif | 52 | 500 |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Mulia Industrindo Tbk
PT Mulia Industrindo Tbk (the company) was established based on Deed No. 15 dated November 5, 1986 of Liliani Handajawati Tamzil S.H., notary in Jakarta, as amended by deed No. 7 dated May 6, 1987 of the same notary.. The company's articles of association have been amended several times, most recently on January 21, 1997 regarding the change of the Company's name and par value per share. The company is one of the companies of the Mulia Group. The company started its commercial operations in 1990.
Selengkapnya di halaman MLIA →Tentang Brigit Biofarmaka Teknologi Tbk.
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Selengkapnya di halaman OBAT →
